SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.

News Shanghai Allist Pharmaceuticals Co., Ltd.

Equities

688578

CNE100005XJ7

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-05-16 pm EDT			5-day change	1st Jan Change
59.6 ^CNY	+0.03%		-7.08%	+43.06%

May. 09	Abbisko Cayman Unit's Cancer Drug To Be Clinically Tested in Combination with Shanghai Allist's Furmonertinib	MT
Apr. 25	Shanghai Allist Pharmaceuticals Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Abbisko Cayman Unit's Cancer Drug To Be Clinically Tested in Combination with Shanghai Allist's Furmonertinib	May. 08	MT
Shanghai Allist Pharmaceuticals Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 25	CI
InnoCare Announces Dosing of First Patient in Clinical Study of the Combination of SHP2 Inhibitor ICP-189 and EGFR Inhibitor Furmonertinib	Apr. 01	AQ
Shanghai Allist Pharmaceuticals Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 23	CI
Shanghai Allist Pharmaceuticals Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-25	CI
Shanghai Allist Pharmaceuticals Co., Ltd.(XSSC:688578) added to S&P Global BMI Index	23-09-18	CI
InnoCare Announces Approval of Clinical Trial of SHP2 Inhibitor ICP-189 in Combination with EGFR Inhibitor Furmonertinib	23-09-14	AQ
Allist Pharmaceuticals Co., Ltd. and ArriVent Biopharma, Inc. Announce Interim Results from Ongoing Phase 1B Trial with Furmonertinib At the 2023 World Conference on Lung Cancer	23-09-10	CI
Shanghai Allist Pharmaceuticals Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-28	CI
Shanghai Allist Pharmaceuticals Gets Nod to Advance Trial of Lung Cancer Treatment	23-08-23	MT
Chinese healthcare stocks hit by stepped up anti-graft crackdown	23-08-09	RE
Shanghai Allist Pharmaceuticals Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-28	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Stock Market
Equities
688578 Stock
News Shanghai Allist Pharmaceuticals Co., Ltd.

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

BENEFIT NOW